Target intelligence / Profile preview

Novel Pumilio domain-containing protein KIAA0020 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Novel Pumilio domain-containing protein KIAA0020 pseudogene (ENSG00000261208) is a human pseudogene annotated as a noncoding remnant of a gene similar to KIAA0020, which contains a Pumilio domain[1][2]. This locus does not code for a functional protein and is considered a pseudogene, typically regarded as genetically inactive, though emerging evidence indicates some pseudogenes can have regulatory RNA roles in gene expression or disease[3][4]. There is no evidence this specific pseudogene is a protein, receptor, or therapeutic target; it is not catalogued as a drug target nor established as a biomarker or disease gene. Notes: - This entity is a pseudogene, meaning it does not produce a protein and is not recognized as a validated target for therapy, diagnosis, or biomarker use[1][3][4]. - There is nothing to indicate it is a misspelling, but the entry is *not* a true target in the conventional biomedical sense; rather, it is a non-functional gene fragment. - The GeneCards database entry classifies it specifically as a pseudogene and does not provide protein, pathway, or drug information[1]. - Some pseudogenes are involved in regulatory mechanisms (such as acting as decoys for microRNAs or generating regulatory RNAs), but there is no evidence specific to this locus for such function[3][4].

Other names
Pumilio domain-containing protein KIAA0020-like pseudogeneLOC100131689
02

Biological functions

Other (no known protein-coding function; potential regulatory noncoding RNA effects as for some pseudogenes)
03

Disease associations

Other (no established direct disease roles)

Beyond the preview

Go deeper on Novel Pumilio domain-containing protein KIAA0020 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel Pumilio domain-containing protein KIAA0020 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call